Safety study of J4 in healthy volunteers
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new drug called J4 in healthy adults to see if it is safe and how the body processes it. Healthy volunteers aged 18 to 64 may join to help researchers learn about the drug's effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 64 years old.
- Your weight is within a healthy range for your height (BMI between 18 and 30).
- You are generally healthy, with no major medical conditions like heart disease, hepatitis, or HIV.
- If you are able to have children, you agree to use highly effective birth control or be abstinent during and for 90 days after the study.
- You will not donate sperm or eggs during the study and for 90 days after.
- You do not use tobacco or nicotine products, drink too much caffeine or alcohol, or take certain medications or supplements.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new medicine called GSM-779690T in healthy volunteers to see how safe it is and how the body handles it. Participating could help determine if the medicine is worth testing in people with certain conditions later.
This trial tests a new medicine called LY4006895 in two groups: healthy volunteers and people with early symptomatic Alzheimer's disease. It aims to see how the drug works in the body and if it might help memory and thinking.
This study tests a new medication, CORT108297, that may help protect the brain from the harmful effects of stress in people at risk for Alzheimer's disease. It is looking for adults age 55 and older who either have mild memory problems or are healthy but have a family history, APOE4 gene, or memory concerns.
This is an early-stage safety study testing a new drug called JPH034 in healthy volunteers. Researchers want to see how the drug is tolerated and what happens to it in your body.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This early-phase study tests a new drug in healthy volunteers to see how safe it is and how the body processes it. It helps doctors decide the right dose for future studies.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.